{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:52:36Z","timestamp":1780469556356,"version":"3.54.1"},"reference-count":11,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":2650,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><jats:p>Pathological gambling is a disabling disorder experienced by about 1% of adults. We randomised 233 participants (41.6% women) 1:1:1 to nalmefene (20 or 40 mg) or placebo. In analyses performed using an intention-to-treat (ITT) population, nalmefene failed to show statistically significant differences from placebo on primary and secondary outcomes. Post hoc analyses of only participants who received a full titration of the medication for at least 1 week demonstrated that nalmefene 40 mg\/day resulted in significantly greater reductions on the primary outcome measure. These findings suggest that medication dosing may be an important consideration in achieving symptom control.<\/jats:p><\/jats:sec>","DOI":"10.1192\/bjp.bp.110.078105","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T22:22:44Z","timestamp":1285885364000},"page":"330-331","source":"Crossref","is-referenced-by-count":107,"title":["Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study"],"prefix":"10.1192","volume":"197","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Odlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000253221_ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110040006"},{"key":"S0007125000253221_ref8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","article-title":"The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","volume":"166","author":"Kim","year":"2009","journal-title":"Psychiatry Res"},{"key":"S0007125000253221_ref10","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0403"},{"key":"S0007125000253221_ref11","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.65.5.727"},{"key":"S0007125000253221_ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.303"},{"key":"S0007125000253221_ref1","article-title":"Naltrexone, an antagonist for the treatment of heroin dependence","volume":"23","author":"Martin","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"S0007125000253221_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01079-4"},{"key":"S0007125000253221_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10899-005-5557-3"},{"key":"S0007125000253221_ref6","volume-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"S0007125000253221_ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.137"},{"key":"S0007125000253221_ref9","doi-asserted-by":"publisher","DOI":"10.2307\/2529876"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000253221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T21:27:36Z","timestamp":1556400456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000253221\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0007125000253221"],"URL":"https:\/\/doi.org\/10.1192\/bjp.bp.110.078105","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}